C0015689||Omega-3
C0428462||Serum Lipid Profile
C0019004||Hemodialysis
C0206034||Randomized Clinical Trial
C0015689||omega-3
C0019004||hemodialysis
C0015689||omega-3
C0428462||lipid profile
C0022661||end-stage renal disease
C0022661||end-stage renal disease
C0019004||hemodialysis
C0022661||end-stage renal disease
C0011946||dialysis
C0019994||Rasoul-e-Akram and Madaen Hospitals
C0206034||randomized clinical trial
C0034656||block randomization method
C0015689||omega-3
C0178913||Blood sample
C0428462||measurement of lipid profile
C0518015||serum hemoglobin
C0201657||C-reactive protein
C0184661||interventions
C0023822||HDL-C
C0015689||omega-3
C1828170||MD
C0441610||reduction
C0600061||serum creatinine level
C0015689||omega-3
C1828170||MD
C0918012||indices
C1287372||serum triglyceride
C0428466||total cholesterol
C0019029||serum hemoglobin levels
C0034980||multivariable linear regression analysis
C0392885||serum HDL level
C0011946||dialysis
C0428472||level of serum HDL-C
C3161035||regression model
C0600061||serum creatinine
C0392885||serum HDL level
C0015689||omega-3
C0011946||dialysis
C1947907||consumption
C0015689||omega-3
C0600061||serum creatinine